LPC
PFE icon

Loeb Partners Corp’s Pfizer PFE Stock Holding History

Loeb Partners Corp’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,045
Closed -$81K – 97
2019
Q1 		$81K Sell
2,045
-6,403
-76% -$256K 1.67% 13
2018
Q4 		$349K Hold
8,448
– – 0.16% 104
2018
Q3 		$353K Sell
8,448
-21,080
-71% -$812K 0.13% 116
2018
Q2 		$1.02M Buy
+29,528
New +$1.01M 0.26% 89
2018
Q1 		– Sell
-13,386
Closed -$460K – 140
2017
Q4 		$460K Hold
13,386
– – 0.14% 118
2017
Q3 		$453K Sell
13,386
-18,129
-58% -$583K 0.14% 121
2017
Q2 		$1M Sell
31,515
-11,804
-27% -$372K 0.29% 81
2017
Q1 		$1.41M Buy
43,319
+8,642
+25% +$272K 0.42% 59
2016
Q4 		$1.07M Hold
34,677
– – 0.36% 67
2016
Q3 		$1.11M Buy
+34,677
New +$1.16M 0.4% 62
2016
Q2 		– Sell
-151,038
Closed -$4.25M – 174
2016
Q1 		$4.25M Sell
151,038
-5,270
-3% -$151K 1.52% 20
2015
Q4 		$4.79M Buy
156,308
+31,304
+25% +$985K 1.53% 15
2015
Q3 		$3.73M Sell
125,004
-4,216
-3% -$135K 1.37% 17
2015
Q2 		$4.11M Sell
129,220
-8,222
-6% -$268K 1.19% 23
2015
Q1 		$4.54M Buy
137,442
+21,080
+18% +$670K 1.33% 20
2014
Q4 		$3.44M Sell
116,362
-31,830
-21% -$913K 1.02% 28
2014
Q3 		$4.16M Sell
148,192
-18,972
-11% -$532K 1.38% 21
2014
Q2 		$4.71M Sell
167,164
-844
-0.5% -$24.1K 1.43% 21
2014
Q1 		$5.12M Sell
168,008
-2,635
-2% -$78.6K 1.72% 13
2013
Q4 		$4.96M Buy
170,643
+738
+0.4% +$21.5K 1.58% 14
2013
Q3 		$4.63M Sell
169,905
-2,108
-1% -$57.4K 1.56% 15
2013
Q2 		$4.57M Buy
+172,013
New +$4.75M 1.67% 15

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loeb Partners Corp's PFE Position: Q2 2019 in Review

Loeb Partners Corp sold out of Pfizer (PFE) in Q2 2019, closing a stake of 2,045 shares — an estimated $81K sold.

Loeb Partners Corp first reported a position in PFE in Q2 2013 and held it in 22 quarters. The position peaked at $5.12M in Q1 2014. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Loeb Partners Corp reported no remaining Pfizer position as of Q2 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 2,045 Pfizer shares in Q2 2019, an estimated $81K.
  • Loeb Partners Corp first reported a position in Pfizer in Q2 2013 and held it in 22 quarters.
  • Loeb Partners Corp's Pfizer position peaked at $5.12M in Q1 2014.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.